Reimbursement Challenges and Solutions with Molecular Biomarker TestingVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. Geoffrey Oxnard and Lauren Ritterhouse consider the current landscape of reimbursement for molecular biomarker testing, the need to run FDA-approved tests, and the role of CMS and local Medicare providers in testing reimbursement.
Atheer Kaddis presents his own personal advice on what pharmacists should do to navigate through the healthcare system.Supported through funding from Incyte
John Hennessy provides a few benefits of personalized medicine as it effects the ability to make better treatment choices earlier rather than later